SCHEMBL24239251

SCHEMBL24239251

CNn1cnc2c(=O)n3cc[nH]c3nc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21362231 0.81 CDK1 (0.36) —
SCHEMBL21871805 0.78 CDK1 (0.42) —
SCHEMBL21372042 0.78 PI4KA (0.37) —
SCHEMBL30089497 0.70 — —
SCHEMBL21137628 0.65 HPRT1 (0.49) —
SCHEMBL20908767 0.65 ALDH1A1 (0.59) —
SCHEMBL21758938 0.65 XDH (0.36) —
SCHEMBL22326671 0.65 HPGD (0.43) —
SCHEMBL1576524 0.61 ALDH1A1 (0.41) —
SCHEMBL7016511 0.60 KDM5B (0.44) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11685761-B2 Cyclic di-nucleotide compounds as sting agonists MERCK SHARP & DOHME LLC (US) 2023-06-27 — — US disclosed
US-20220033435-A1 Cyclic Di-Nucleotide Compounds as STING Agonists MERCK SHARP & DOHME CORP. (US) 2022-02-03 — — US disclosed
Send feedback